How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

5,172 results for

Headache in Pregnancy

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

5101. Are there any risks associated with the use of topical insect repellants (e.g. DEET) in the first trimester of pregnancy?

). One RCT in pregnant women [2 nd & 3 rd trimesters] (897 refugees in a Thai forest area of low malaria endemicity) comparing DEET (median dose 214.2 g per pregnancy) versus a cosmetic cream found no differences in weekly reporting of headache, dizziness, or nausea and vomiting. It also found no adverse effects on infant survival, growth, or development at either birth or 1 year (survival 95.2% with DEET v 94.0% without DEET, P = 0.57; mean weight at 1 year 7983 g with DEET v 7984 g without DEET) (3 (...) Are there any risks associated with the use of topical insect repellants (e.g. DEET) in the first trimester of pregnancy? Are there any risks associated with the use of topical insect repellants (e.g. DEET) in the first trimester of pregnancy? - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING

2003 TRIP Answers

5102. A study of the efficacy of cervical ripening with nitric oxide donor versus placebo for cervical priming before second-trimester termination of pregnancy. (Abstract)

A study of the efficacy of cervical ripening with nitric oxide donor versus placebo for cervical priming before second-trimester termination of pregnancy. This was a double-blind randomized control study to evaluate the efficacy of cervical priming by nitric oxide donor before second-trimester induced abortion. One-hundred healthy women with a singleton pregnancy between 14 and 20 weeks of gestation were randomized into either 40 mg isosorbide mononitrate or placebo, given intravaginally 12 h (...) before induction. This was followed by intravaginal misoprostol induction. The induction-abortion interval, abortion rate, side effects and the woman's acceptability of the priming agent were recorded. All women completed the study and there was no severe complication recorded. There was no significant difference in the induction-abortion interval and abortion rate between the two groups. Isosorbide mononitrate group reported significantly more side effects of headache. More than 90% of the women

2003 Contraception Controlled trial quality: uncertain

5103. Ketanserin versus alpha-methyldopa in the treatment of hypertension during pregnancy: a preliminary report. (Abstract)

Ketanserin versus alpha-methyldopa in the treatment of hypertension during pregnancy: a preliminary report. The antihypertensive efficacy of acute treatment with the serotonin receptor antagonist, ketanserin, in women with preeclampsia has been recently documented. The purpose of this study was to determine the safety and efficacy of chronic ketanserin treatment in a group of 20 hypertensive pregnant women: 10 received daily oral doses of ketanserin (20-80 mg), and 10 were treated with oral (...) alpha-methyldopa (500-2000 mg). This study includes (a) patients with a sustained elevation of systolic blood pressure higher than 159 mm Hg and/or diastolic blood pressure higher than 99 mm Hg at bed rest, and (b) hypertensive patients with systolic blood pressure higher than 140 mm Hg or diastolic blood pressure higher than 90 mm Hg with superimposed symptoms such as headaches, stomach aches, and neurological disturbances. A significant and comparable decrease in blood pressure was noted in both

1987 Journal of cardiovascular pharmacology Controlled trial quality: uncertain

5104. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study. (Abstract)

Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study. This study was undertaken to compare the effectiveness of mifepristone orally administered at 24 or 48 hours before first-trimester vacuum aspiration abortion with that of vaginally administered misoprostol as a cervical priming agent.In a randomized comparative trial 90 women who requested surgical termination of pregnancy were randomly (...) the cervix (P =.06). There were no significant differences among the 3 groups in the intraoperative blood loss, in the operating time, or in patient acceptability. Side effects such as hot flushes and headaches were significantly higher among women who received mifepristone 24 or 48 hours before the operation than among those who received misoprostol (P =.01 and P =. 002, respectively).Mifepristone is an effective cervical priming agent when orally administered 48 hours before vacuum aspiration

2000 American journal of obstetrics and gynecology Controlled trial quality: uncertain

5105. A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days gestation. (Abstract)

A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days gestation. Of the total women included in the study, 96 women chose to receive misoprostol 600 microg sublingually while 53 women received misoprostol 800 microg vaginally 36-48 h after receiving mifepristone 200 mg. Complete abortion occurred in 93 women (98.9%) in the sublingual and 51 women (96.2%) in the vaginal group (p = 0.27). The mean induction (...) -to-abortion interval was 3.2 h (SD = 1.4) in the sublingual and 4.1 h (SD = 1.5) in the vaginal group (p = 0.02). The mean gestation at abortion in weeks was 7.1 (SD = 1.0) in the sublingual and 7.7 (SD = 1.3) in the vaginal group (p = 0.003). Women in the sublingual group experienced more vomiting (p = 0.03), diarrhea (p = 0.02) and unpleasant taste in their mouth (p = 0.0001) while those in the vaginal group experienced more headache (p = 0.002). Of women in the sublingual group, 77% were satisfied

2003 Contraception

5106. Early pregnancy termination with vaginal misoprostol before and after 42 days gestation. (Abstract)

Early pregnancy termination with vaginal misoprostol before and after 42 days gestation. Misoprostol is a prostaglandin E(1) analogue that has been used for medical abortion. We conducted this prospective study to compare the efficacy of vaginal misoprostol for abortion in women at a gestational age of <42 days and in women at a gestational age of 42-56 days.A total of 160 women seeking medical termination of a pregnancy of <56 days were enrolled in the study. Medical termination was performed (...) using 800 micro g of vaginal misoprostol, repeated every 24 h for a maximum of three doses.The overall complete abortion rate was 91.3%. In group A (gestation <42 days) complete abortion occurred in 96.3% of women, whereas in group B (gestation = 42-56 days) complete abortion occurred in 86.3% of women (P < 0.025). The two groups did not differ significantly with respect to side-effects (incidence of pain, bleeding, nausea, diarrhoea, fever and headache). Women who had aborted successfully were

2002 Human Reproduction

5107. Cerebral metastases of a choriocarcinoma during pregnancy. (Abstract)

Cerebral metastases of a choriocarcinoma during pregnancy. Cerebral metastasis of choriocarcinoma during pregnancy is rare. Described is the fourth case in the literature.A pregnant women at 28 weeks' gestation sought care for headaches followed by loss of consciousness. The diagnosis of choriocarcinoma metastases was made on the basis of the combination of cerebral and pulmonary lesions, all suspected to be metastatic, and a high beta human chorionic gonadotropin level. A premature cesarean

2003 Obstetrics and Gynecology

5108. Thrombotic thrombocytopenic purpura and human immunodeficiency virus complicating pregnancy. (Abstract)

-positive patient complained of easy bruising, hematuria, fever, myalgias, and headache during the second trimester of pregnancy. Laboratory testing revealed hemolytic anemia and severe thrombocytopenia. Bone marrow biopsy was consistent with thrombocytopenic purpura. The patient recovered after plasmapheresis. At 36 weeks' gestation, she was delivered for preeclampsia and fetal growth restriction.Absence of the classic pentad seen in thrombocytopenic purpura among pregnant HIV-positive patients may (...) Thrombotic thrombocytopenic purpura and human immunodeficiency virus complicating pregnancy. Thrombotic thrombocytopenic purpura is a rare but serious medical complication, but is relatively common among patients with human immunodeficiency virus (HIV) infection. It is characterized by the pentad of thrombocytopenia, microangiopathic hemolytic anemia, neurological symptoms, fever, and renal abnormalities. However, the pentad is often incomplete, especially in HIV-positive patients.An HIV

2002 Obstetrics and Gynecology

5109. Management Strategy for Meningioma in Pregnancy: A Clinical Study Full Text available with Trip Pro

Management Strategy for Meningioma in Pregnancy: A Clinical Study We retrospectively studied 18 pregnant women from 600 cases of meningioma treated at this Institution between 1986 and 2001. The variables evaluated included clinical presentation; radiological findings; timing and extent of surgical resection; and an overview of gestational, clinical, and surgical outcomes. Visual impairment was the chief complaint followed by headache and seizures. The tumors involved the tuberculum sella (8 (...) ), sphenoid wing (4), convexity (2), parasellar (2), cerebellopontine angle (CPA) (1), and anterior falx (1). Gross total resection was achieved in 14, and subtotal resection was achieved in two patients. There were no related fetal or maternal deaths. Of seven patients with advanced or progressive visual impairment who underwent resection during pregnancy, three improved noticeably, two worsened, and two were unchanged. Five other patients with visual disturbance achieved full-term spontaneous delivery

2003 Skull Base

5110. Sumatriptan 4 mg Statdose in the Acute Treatment of Cluster Headache

Sumatriptan 4 mg Statdose in the Acute Treatment of Cluster Headache Sumatriptan 4 mg Statdose in the Acute Treatment of Cluster Headache - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Sumatriptan 4 mg (...) Statdose in the Acute Treatment of Cluster Headache The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00399243 Recruitment Status : Unknown Verified January 2009 by Diamond Headache Clinic. Recruitment status was: Recruiting First Posted : November 14, 2006 Last Update Posted : February 2, 2009 Sponsor

2006 Clinical Trials

5111. Effect of Small Versus Large Epidural Needles on Postdural Puncture Headache Study

gestation pregnancy Known contraindications to use of epidural analgesia Pregnancy-induced hypertension Investigator concern for maternal or neonatal welfare Receipt of spinal or epidural anesthesia within 14 days of labour epidural request Women with chronic headaches (defined as headaches that occur 15 or more days per month for more than 3 months) Already participated in study History of narcotic abuse Contacts and Locations Go to Information from the National Library of Medicine To learn more about (...) for additonal information Responsible Party: Dr. Pamela Angle, Associate Professor, Director, Associate Scientist, Anesthesiologist, Sunnybrook Health Sciences Centre ClinicalTrials.gov Identifier: Other Study ID Numbers: 1-PAngle First Posted: August 31, 2006 Last Update Posted: June 23, 2015 Last Verified: June 2015 Keywords provided by Dr. Pamela Angle, Sunnybrook Health Sciences Centre: Parturient Obstetrics Pregnancy Labour Labor Headache Epidural Analgesia Anesthesia Anaesthesia Additional relevant

2006 Clinical Trials

5112. A Research Study To Compare Two Kinds Of Daily Headache

A Research Study To Compare Two Kinds Of Daily Headache A Research Study To Compare Two Kinds Of Daily Headache - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Research Study To Compare Two Kinds Of Daily (...) Headache The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00335803 Recruitment Status : Completed First Posted : June 12, 2006 Last Update Posted : January 23, 2009 Sponsor: Thomas Jefferson University Information provided by: Thomas Jefferson University Study Details Study Description Go to Brief

2006 Clinical Trials

5113. A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches

A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Double (...) -Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00391755 Recruitment Status : Terminated (Failure to recruit necessary number of patients.) First Posted : October 24, 2006 Last Update Posted : February 10, 2012 Sponsor: Charlottesville

2006 Clinical Trials

5114. Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache

in the protocol) for at least three months prior to enrolment with contraception maintained for at least 7 days after the last dose of study medication and they must have a negative pregnancy test at screening with no intention of becoming pregnant during the study period. Exclusion Criteria: Patients with a diagnosis of migraine according to the diagnostic criteria of the International Classification of Headache Disorders at age 50 years or more. Experience frequent non-migraine headache Patients with pure (...) Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more

2006 Clinical Trials

5115. Epidural Blood Patch on the Resolution of Postdural Puncture Headache (PDPH)

Epidural Blood Patch on the Resolution of Postdural Puncture Headache (PDPH) Epidural Blood Patch on the Resolution of Postdural Puncture Headache (PDPH) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Epidural Blood Patch on the Resolution of Postdural Puncture Headache (PDPH) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00373074 Recruitment Status : Terminated (Lack of subject population for PI) First Posted : September 7, 2006 Last Update Posted : February 6, 2009 Sponsor: The University

2006 Clinical Trials

5116. Comparison of 25-gauge, Quincke and Whitacre needles for postdural puncture headache in obstetric patients. (Abstract)

, Karachi from November 1, 2003-April 15, 2004.One hundred females, aged 18-35 years, ASA physical status I and II, with singleton pregnancy undergoing elective or emergency cesarean section under spinal anesthesia were randomly allocated to receive spinal anesthesia either by using 25-gauge Quincke or 25-gauge Whitacre needles. Patients were followed for 3 days postoperatively. Headache, its relation with posture, onset, duration, severity and response to the treatment were recorded.Compared (...) Comparison of 25-gauge, Quincke and Whitacre needles for postdural puncture headache in obstetric patients. To compare the frequency of postdural puncture headache (PDPH) and failure rate of spinal anesthesia using 25-gauge Quincke and 25-gauge Whitacre needles in obstetric patients.Single blinded, interventional experimental study.This study was conducted at the Department of Anesthesiology, Pain Management and Surgical Intensive Care Unit, Dow University of Health Sciences and Civil Hospital

2004 Journal of the College of Physicians and Surgeons--Pakistan : JCPSP Controlled trial quality: uncertain

5117. Intrapartum analgesia and its association with post-partum back pain and headache in nulliparous women. (Abstract)

and ninety women received epidural analgesia (EPIDURAL) and 302 received other methods of pain relief including CMS. Back pain was common before, during and after pregnancy, and risk factors for post-partum back pain at six months were back pain prior to pregnancy or at two months post-partum. Epidural analgesia, mode of delivery, spontaneous or induced labour, birthweight and back pain during pregnancy had no significant relationship with post-partum back pain at six months. Headache was significantly (...) more common in the EPIDURAL group during pregnancy and at two months post-partum, but not at six months. Migraine was not associated with intrapartum analgesia.This analysis supports previous research suggesting that epidural analgesia is not a significant risk factor for persisting post-partum back pain, headache or migraine.

2006 The Australian & New Zealand journal of obstetrics & gynaecology Controlled trial quality: uncertain

5118. Posterior reversible encephalopathy syndrome with vasospasm in a postpartum woman after postdural puncture headache following spinal anesthesia. Full Text available with Trip Pro

Posterior reversible encephalopathy syndrome with vasospasm in a postpartum woman after postdural puncture headache following spinal anesthesia. We describe a postpartum woman who, after an uneventful pregnancy, developed posterior reversible encephalopathy syndrome after spinal anesthesia, complicated by postdural puncture headache.

2007 Anesthesia and Analgesia

5119. Internal carotid artery dissection as a cause of headache in the second trimester. (Abstract)

Internal carotid artery dissection as a cause of headache in the second trimester. Carotid dissection is a rare cause of headache in pregnancy.A 38-year-old woman gravida 5 para 3-0-1-3 presented at 21 weeks with a headache. Imaging revealed carotid artery dissection.Carotid artery dissection may cause refractory headache in pregnancy. Prompt anticoagulation is required due to the potential for stroke.

2007 American Journal of Obstetrics and Gynecology

5120. Management of Headache Disorders: A Clinical Trial Screening for Prognostic Patient Characteristics

) for this headache complaint during the last two months Pregnancy Red flags as described in the Dutch General Practitioners Headache Guideline Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00298142 Locations Layout table for location information Belgium GP-De (...) Management of Headache Disorders: A Clinical Trial Screening for Prognostic Patient Characteristics Management of Headache Disorders: A Clinical Trial Screening for Prognostic Patient Characteristics - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please

2006 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>